Eurofins-Cerep SA (ALECR.PA)
25000 €
+2,600.00 (+11.61%)
Rating:
Recommendation:
-
| Symbol | ALECR.PA |
|---|---|
| Price | 25000 € |
| Beta | 0.538 |
| Volume Avg. | - |
| Market Cap | 126.100M |
| Shares () | - |
| 52 Week Range | 22200.0-29200.0 |
| 1y Target Est | - |
| DCF Unlevered | ALECR.PA DCF -> | |
|---|---|---|
| DCF Levered | ALECR.PA LDCF -> | |
| ROE | 22.53% | Buy |
| ROA | 16.22% | Buy |
| Operating Margin | - | |
| Debt / Equity | 0.01% | Neutral |
| P/E | 13.68 | Strong Buy |
| P/B | 2.22 | Strong Buy |
About
Download (Excel)Eurofins Cerep SA provides various drug discovery services to pharmaceutical and biotechnology companies worldwide. The company's research services include compound management, high-throughput screening, in vitro safety profiling, lead optimization (or SAR) profiling, in vitro ADME profiling, and in vivo PK. It also offers assay design and development services. The company was formerly known as Cerep SA and changed its name to Eurofins Cerep SA in June 2014. Eurofins Cerep SA was founded in 1989 and is based in Vienne, France.